{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Age&page=58", "query": { "intervention": "Age", "page": 58 }, "page_size": 10 }, "pagination": { "page": 58, "page_size": 10, "total_count": 8270, "total_pages": 827, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Age&page=59&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Age&page=57&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-04T15:08:04.048Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01296516", "title": "Postpartum Weight Loss and Exercise (PRIDE)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Gestational Diabetes", "Glucose Intolerance" ], "interventions": [ { "name": "Non-intervention group", "type": "BEHAVIORAL" }, { "name": "Face to face", "type": "BEHAVIORAL" }, { "name": "Telehelath Group", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Pennington Biomedical Research Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 7, "start_date": "2011-02", "completion_date": "2017-12", "has_results": false, "last_update_posted_date": "2021-08-24", "last_synced_at": "2026-11-04T15:08:04.048Z", "location_count": 1, "location_summary": "Baton Rouge, Louisiana", "locations": [ { "city": "Baton Rouge", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01296516" }, { "nct_id": "NCT05236738", "title": "A Study to Compare the Drug Levels of Atazanavir and Cobicistat Between the Coadministration of Age-Appropriate Mini-Tablet Formulations and the Coadministration of the Individual Reference Products in Healthy Adults Under Fed Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "Atazanavir", "type": "DRUG" }, { "name": "Cobicistat", "type": "DRUG" }, { "name": "Atazanavir/Cobicistat Mini-tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 42, "start_date": "2022-05-13", "completion_date": "2022-07-26", "has_results": false, "last_update_posted_date": "2022-10-31", "last_synced_at": "2026-11-04T15:08:04.048Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05236738" }, { "nct_id": "NCT07230834", "title": "Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Geographic Atrophy (GA)" ], "interventions": [ { "name": "Pozelimab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 54, "start_date": "2026-01-19", "completion_date": "2028-07-03", "has_results": false, "last_update_posted_date": "2026-08-05", "last_synced_at": "2026-11-04T15:08:04.048Z", "location_count": 5, "location_summary": "Lakewood, Colorado • East Weymouth, Massachusetts • Austin, Texas + 2 more", "locations": [ { "city": "Lakewood", "state": "Colorado" }, { "city": "East Weymouth", "state": "Massachusetts" }, { "city": "Austin", "state": "Texas" }, { "city": "Dallas", "state": "Texas" }, { "city": "The Woodlands", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07230834" }, { "nct_id": "NCT04733534", "title": "An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Frailty", "Childhood Cancer" ], "interventions": [ { "name": "Dasatinib plus Quercetin", "type": "DRUG" }, { "name": "Fisetin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2022-06-06", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-11-04T15:08:04.048Z", "location_count": 1, "location_summary": "Memphis, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04733534" }, { "nct_id": "NCT05067634", "title": "Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Partial Epilepsy" ], "interventions": [ { "name": "Xcopri", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SK Life Science, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "2 Years to 18 Years" }, "enrollment_count": 154, "start_date": "2022-01-10", "completion_date": "2026-10-02", "has_results": false, "last_update_posted_date": "2026-10-16", "last_synced_at": "2026-11-04T15:08:04.048Z", "location_count": 14, "location_summary": "Phoenix, Arizona • Palo Alto, California • Hartford, Connecticut + 11 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Palo Alto", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Sandy Springs", "state": "Georgia" }, { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05067634" }, { "nct_id": "NCT04546399", "title": "A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Down Syndrome", "Recurrent B Acute Lymphoblastic Leukemia" ], "interventions": [ { "name": "3-Dimensional Conformal Radiation Therapy", "type": "RADIATION" }, { "name": "Asparaginase Erwinia chrysanthemi", "type": "DRUG" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Blinatumomab", "type": "BIOLOGICAL" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Calaspargase Pegol", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Hydrocortisone Sodium Succinate", "type": "DRUG" }, { "name": "Lumbar Puncture", "type": "PROCEDURE" }, { "name": "Mercaptopurine", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Nivolumab", "type": "BIOLOGICAL" }, { "name": "Pegaspargase", "type": "DRUG" }, { "name": "Vincristine Sulfate", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "DRUG", "PROCEDURE", "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "30 Years", "sex": "ALL", "summary": "1 Year to 30 Years" }, "enrollment_count": 461, "start_date": "2020-12-17", "completion_date": "2028-06-30", "has_results": false, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-11-04T15:08:04.048Z", "location_count": 211, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 151 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Kingman", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04546399" }, { "nct_id": "NCT03701516", "title": "Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Myopia" ], "interventions": [ { "name": "etafilcon A with novel molding process", "type": "DEVICE" }, { "name": "etafilcon A with current molding process", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Johnson & Johnson Vision Care, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 268, "start_date": "2018-09-24", "completion_date": "2019-04-01", "has_results": true, "last_update_posted_date": "2022-04-27", "last_synced_at": "2026-11-04T15:08:04.048Z", "location_count": 12, "location_summary": "Rocklin, California • Fleming Island, Florida • Jacksonville, Florida + 9 more", "locations": [ { "city": "Rocklin", "state": "California" }, { "city": "Fleming Island", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Longwood", "state": "Florida" }, { "city": "Maitland", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03701516" }, { "nct_id": "NCT00997984", "title": "Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Attention-Deficit/Hyperactivity Disorder" ], "interventions": [ { "name": "extended-release guanfacine hydrochloride (SPD503)", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "extended-release guanfacine hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "6 Years to 12 Years" }, "enrollment_count": 340, "start_date": "2009-11-17", "completion_date": "2010-10-09", "has_results": true, "last_update_posted_date": "2021-06-08", "last_synced_at": "2026-11-04T15:08:04.048Z", "location_count": 42, "location_summary": "Little Rock, Arkansas • El Centro, California • Rolling Hills Estates, California + 38 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "El Centro", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Wildomar", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00997984" }, { "nct_id": "NCT04193085", "title": "Wearable Technology to Assess Gait Function in SMA and DMD", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Spinal Muscular Atrophy Type 3", "Duchenne Muscular Dystrophy" ], "interventions": [ { "name": "Observational", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "5 Years", "maximum_age": null, "sex": "ALL", "summary": "5 Years and older" }, "enrollment_count": 39, "start_date": "2019-11-25", "completion_date": "2023-08-31", "has_results": false, "last_update_posted_date": "2024-09-23", "last_synced_at": "2026-11-04T15:08:04.048Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04193085" }, { "nct_id": "NCT07879833", "title": "AI-Personalized Skincare Regimen for Facial Photoaging in Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Photoaging", "Skin Aging" ], "interventions": [ { "name": "AI-personalized skin longevity regimen", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "MDalgorithms Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "35 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "35 Years to 65 Years · Female only" }, "enrollment_count": 43, "start_date": "2025-09-30", "completion_date": "2026-02-13", "has_results": false, "last_update_posted_date": "2026-10-19", "last_synced_at": "2026-11-04T15:08:04.048Z", "location_count": 1, "location_summary": "Richardson, Texas", "locations": [ { "city": "Richardson", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07879833" } ] }